Senestech (NASDAQ:SNES) Posts Quarterly Earnings Results, Misses Estimates By $0.05 EPS

Senestech (NASDAQ:SNES) posted its quarterly earnings data on Tuesday. The company reported ($0.36) earnings per share for the quarter, missing the consensus estimate of ($0.31) by ($0.05), FiscalAI reports. The business had revenue of $1.10 million during the quarter, compared to the consensus estimate of $0.92 million. Senestech had a negative return on equity of 71.89% and a negative net margin of 294.73%.

Senestech Trading Down 9.6%

Shares of NASDAQ:SNES traded down $0.11 during mid-day trading on Tuesday, hitting $1.03. The company had a trading volume of 39,760 shares, compared to its average volume of 364,641. The firm has a fifty day moving average price of $0.85 and a 200 day moving average price of $1.46. The company has a market capitalization of $5.58 million, a PE ratio of -0.75 and a beta of 0.11. The company has a debt-to-equity ratio of 0.02, a current ratio of 6.78 and a quick ratio of 5.81. Senestech has a one year low of $0.55 and a one year high of $3.40.

Insider Activity

In related news, major shareholder Glenbrook Capital Management bought 426,000 shares of the business’s stock in a transaction that occurred on Thursday, October 15th. The shares were acquired at an average cost of $0.77 per share, with a total value of $328,020.00. Following the completion of the purchase, the insider directly owned 1,505,294 shares in the company, valued at $1,159,076.38. The trade was a 39.47% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In the last 90 days, insiders have acquired 1,123,679 shares of company stock worth $814,836. 2.20% of the stock is owned by insiders.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Senestech in a research report on Wednesday, November 4th. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the stock presently has an average rating of “Sell”.

Senestech Company Profile

SenesTech, Inc. is a biotechnology company focused on developing fertility-control technologies for managing animal populations. The company’s approach is designed to reduce reproduction rather than rely solely on lethal control methods, with applications primarily in rodent management. SenesTech’s principal product is ContraPest, a liquid bait designed to reduce fertility in rats by affecting reproductive function in both male and female animals. The product is intended for use in commercial, municipal and other settings where rat populations pose sanitation, health or property risks.